Please login to the form below
Actilyse
This page shows the latest Actilyse news and features for those working in and with pharma, biotech and healthcare.
Daiichi Sankyo licenses clot-busting antibody
as Genentech/Boehringer Ingelheim's Activase/Actilyse (alteplase), but Translational Sciences believes there is significant room for improvement.
Latest news
-
NICE stroke guidance boost for Boehringer's Actilyse
NICE stroke guidance boost for Boehringer's Actilyse. Institute changes guidance on alteplase use. ... More people suffering a stroke in the UK should get treatment with Boehringer Ingelheim's thrombolytic drug Actilyse in the wake of new NICE
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
- Account Manager – Med Comms – London
-
Salary TBC
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
-
Senior Programme Executive
-
Salary TBC
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
-
Senior Medical Writer
-
Great salary and benefits
-
Scientific Director
-
Great salary and bebefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
-
Senior Medical Writer
-
Great salary and bebefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
Subscribe to our email news alerts
PMHub
CAN advertising
Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...
Latest intelligence
- No Voice, No Choice
- Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
Quick links
Infographics
